MK-4827

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK-4827, covering 2012-06-28 to 2016-05-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1) [Phase 1]

See pricing